| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
NeuroBo Pharmaceuticals Inc (NASDAQ: NRBO)
NRBO Technical Analysis
4
| As on 27th Nov 2024 NRBO SHARE Price closed @ 2.36 and we RECOMMEND Buy for LONG-TERM with Stoploss of 2.05 & Strong Buy for SHORT-TERM with Stoploss of 0.50 we also expect STOCK to react on Following IMPORTANT LEVELS. |
NRBOSHARE Price
| Open | 2.35 | Change | Price | % |
| High | 2.44 | 1 Day | 0.01 | 0.43 |
| Low | 2.32 | 1 Week | 0.05 | 2.16 |
| Close | 2.36 | 1 Month | -0.18 | -7.09 |
| Volume | 12978 | 1 Year | 1.88 | 391.67 |
| 52 Week High 6.52 | 52 Week Low 0.38 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| ARBK | 0.37 | 94.74% |
| ARBK | 0.37 | 94.74% |
| NVDA | 153.30 | -2.97% |
| LCID | 2.03 | -3.79% |
| HCTI | 0.03 | 0.00% |
| TSLA | 300.71 | -5.34% |
| HOOD | 92.33 | -1.39% |
| LMDX | 0.02 | 0.00% |
| OPEN | 0.56 | 5.66% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| NRBO Daily Charts |
NRBO Intraday Charts |
Whats New @ Bazaartrend |
NRBO Free Analysis |
|
|
NRBO Important Levels Intraday
| RESISTANCE | 2.59 |
| RESISTANCE | 2.52 |
| RESISTANCE | 2.47 |
| RESISTANCE | 2.43 |
| SUPPORT | 2.29 |
| SUPPORT | 2.25 |
| SUPPORT | 2.20 |
| SUPPORT | 2.13 |
NRBO Forecast July 2025
| 4th UP Forecast | 2.92 |
| 3rd UP Forecast | 2.74 |
| 2nd UP Forecast | 2.63 |
| 1st UP Forecast | 2.52 |
| 1st DOWN Forecast | 2.2 |
| 2nd DOWN Forecast | 2.09 |
| 3rd DOWN Forecast | 1.98 |
| 4th DOWN Forecast | 1.8 |
NRBO Weekly Forecast
| 4th UP Forecast | 2.65 |
| 3rd UP Forecast | 2.56 |
| 2nd UP Forecast | 2.50 |
| 1st UP Forecast | 2.44 |
| 1st DOWN Forecast | 2.28 |
| 2nd DOWN Forecast | 2.22 |
| 3rd DOWN Forecast | 2.16 |
| 4th DOWN Forecast | 2.07 |
NRBO Forecast2025
| 4th UP Forecast | 14.67 |
| 3rd UP Forecast | 10.72 |
| 2nd UP Forecast | 8.28 |
| 1st UP Forecast | 5.84 |
| 1st DOWN Forecast | -1.12 |
| 2nd DOWN Forecast | -3.56 |
| 3rd DOWN Forecast | -6 |
| 4th DOWN Forecast | -9.95 |
NeuroBo Pharmaceuticals Inc ( NASDAQ USA Symbol : NRBO )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
NRBO Business Profile
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for coronavirus, neurodegenerative, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which has completed Phase 2 clinical trial to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of protein; and Gemcabene, an acute indication for COVID-19. NeuroBo Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Boston, Massachusetts. Address: 200 Berkeley Street, Boston, MA, United States, 02116
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service